Dyslipidemia increases the risk of severe COVID-19: a systematic review, meta-analysis, and meta-regression
IS Atmosudigdo, MA Lim, B Radi… - Clinical Medicine …, 2021 - journals.sagepub.com
Objective: This systematic review and meta-analysis aimed to evaluate whether
dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate …
dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate …
Low HDL and high triglycerides predict COVID-19 severity
Lipids are indispensable in the SARS-CoV-2 infection process. The clinical significance of
plasma lipid profile during COVID-19 has not been rigorously evaluated. We aim to …
plasma lipid profile during COVID-19 has not been rigorously evaluated. We aim to …
[HTML][HTML] Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows
that outcomes are markedly heterogeneous between patients. This requires identifying the …
that outcomes are markedly heterogeneous between patients. This requires identifying the …
Development and validation of a hybrid deep learning–machine learning approach for severity assessment of COVID-19 and other pneumonias
Abstract The Coronavirus Disease 2019 (COVID-19) is transitioning into the endemic phase.
Nonetheless, it is crucial to remain mindful that pandemics related to infectious respiratory …
Nonetheless, it is crucial to remain mindful that pandemics related to infectious respiratory …
Characterization by quantitative serum proteomics of immune-related prognostic biomarkers for COVID-19 symptomatology
The COVID-19 pandemic caused by SARS-CoV-2 challenges the understanding of factors
affecting disease progression and severity. The identification of prognostic biomarkers and …
affecting disease progression and severity. The identification of prognostic biomarkers and …
Signaling through FcγRIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19
Patients with COVID-19 present with a wide variety of clinical manifestations.
Thromboembolic events constitute a significant cause of morbidity and mortality in patients …
Thromboembolic events constitute a significant cause of morbidity and mortality in patients …
[HTML][HTML] Introduction to umbrella reviews as a useful evidence-based practice
GJ Choi, H Kang - Journal of lipid and atherosclerosis, 2023 - ncbi.nlm.nih.gov
The umbrella review (UR) is a novel methodological approach that has been established to
address the ever-expanding research volume of published systematic reviews. In this study …
address the ever-expanding research volume of published systematic reviews. In this study …
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship
SF de Medeiros, MMW Yamamoto… - Reviews in Endocrine …, 2022 - Springer
This comprehensive review aimed to evaluate the relationship between SARS-CoV-2
infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and …
infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and …
High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
E Alcántara-Alonso, F Molinar-Ramos… - Clinical nutrition …, 2021 - Elsevier
Background & aims Coronavirus disease 2019 (COVID-19) patients with severe
complications have shown comorbidities with cardiovascular-disease, hypertension and …
complications have shown comorbidities with cardiovascular-disease, hypertension and …
Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review
The novel coronavirus, which began spreading from China Wuhan and gradually spreaded
to most countries, led to the announcement by the World Health Organization on March 11 …
to most countries, led to the announcement by the World Health Organization on March 11 …